Optimizing Next Generation Sequencing for Sensitive Detection of Viral Adventitious Agents in Biologics
Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies
Obtaining extensive in- and at-line input and output analytics combined with machine learning to improve predictive CQA
Advanced Bioprocessing Sensor and Analytical Technologies for Induced Pluripotent Stem Cell Culture Online Monitoring and Automation
Acquisition of a ‘Xevo G2-XS QTof’ Mass Spectrometer and Measurement of Monoclonal Antibody Glycan Heterogeneity by Orthogonal Methodologies